400-859-2883
Your location:Home >News center >Industry News

Industry News

05-242023

Semaglutide: New Therapeutic Potentials

Semaglutide may have the potential to protect against cardiovascular disease, treat NAFLD, fight cancer, alleviate neurodegenerative diseases and reduce addictive behaviors, etc.

Semaglutide: New Therapeutic Potentials
04-252023

Bystander Effects of Antibody-Drug Conjug…

The bystander effect of ADC is expected to solve heterogeneous expression of target antigens (Ag) in metastatic tumor tissues.

Bystander Effects of Antibody-Drug Conjugates
04-232023

List of GLP-1 Receptor Agonists for Diabe…

Glucagon-like peptide-1 (GLP-1), as one of the important targets for the treatment of type 2 diabetes mellitus (T2DM), has obvious therapeutic effect, short half-life and easy to be cleared. …

List of GLP-1 Receptor Agonists for Diabetes & Weight Loss
04-202023

A Comprehensive Guide to ADC Payload Clas…

ADC payloads are critical components of the ADC structure, and their selection and design are crucial for achieving optimal therapeutic efficacy and minimizing toxicity.

A Comprehensive Guide to ADC Payload Classes
04-102023

Covalent PROTACs, An Emerging Protein Deg…

In recent years, a new technology that combines covalent inhibitors and PROTACs has emerged—covalent PROTAC technology, including reversible covalent and irreversible covalent PROTAC.

Covalent PROTACs, An Emerging Protein Degradation Technology
03-302023

Multifunctional Peptides: Novel Direction…

The emerging technologies such as multifunctional peptides, binding peptides, peptide conjugates, oral peptides, long-acting, and delivery systems have greatly contributed to the prosperity o…

Multifunctional Peptides: Novel Direction of Peptide Drug Development
03-242023

Peptide Drug Conjugates (PDCs): Novel Tar…

Peptide-drug conjugates (PDCs) are the next generation of targeted therapeutics after ADCs, and their core advantages are enhanced cell permeability and improved drug selectivity. In recent y…

Peptide Drug Conjugates (PDCs): Novel Targeted Therapeutics For Cancer
03-172023

Innovative Treatments For Cervical Cancer…

In recent years, the emergence of targeted therapy and immunotherapy has brought new hope to patients with advanced cervical cancer. Currently, two targeted therapies and two immunotherapies …

Innovative Treatments For Cervical Cancer
03-132023

Overview of Oligonucleotide Therapeutics …

To date, 15 oligonucleotide therapeutics have been approved by the U.S. Food and Drug Administration (FDA) .

Overview of Oligonucleotide Therapeutics & Its Delivery
02-282023

Target And Clinical Trial Progress of ADC…

A total of 15 ADC drugs have been approved for hematological malignancies and solid tumors worldwide till now. In addition, there are currently more than 100 ADC candidates are in various sta…

Target And Clinical Trial Progress of ADC In Prostate Cancer